Characterization and clinical outcomes of rare biliary adenosquamous carcinoma
BASC is a rare disease with an increased incidence, highlighting the diagnostic challenges. BASC population was associated with a poor prognostic and limited therapeutic response. Further molecular investigations should be performed to investigate new therapeutic options.
Authors
- Alexandre Doussot (ORCID: https://orcid.org/0000-0003-0543-1793)
- Chloé Molimard (ORCID: https://orcid.org/0000-0001-9578-1652)
- Angélique Vienot (ORCID: https://orcid.org/0000-0002-0381-7601)
- Franck Monnien (ORCID: https://orcid.org/0000-0002-2799-3730)
- Lucine Vuitton (ORCID: https://orcid.org/0000-0001-9845-6572)
- Christophe Borg (ORCID: https://orcid.org/0000-0002-2167-1458)
- Julie Henriques (ORCID: https://orcid.org/0000-0002-0674-0953)
- Francine Fein
- Anne Ruffat
Institutions
- Inserm (FR)
- Centre Hospitalier Universitaire de Besançon (FR)
- Methodology and Quality of Life Unit in Oncology (FR)
- Université de Franche-Comté (FR)
Publication Details
- Journal
- European Journal of Surgical Oncology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1016/j.ejso.2025.110015
- Citations
- 3
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 6.02